Article
Chronic Myelogenous Leukemia,BCR-ABL1+
15 Jul 2009
Abstract excerpt
Session 1 of the 2007 Workshop of the Society for Hematopathology/European Association for Haematopathology focused on chronic myelogenous leukemia, BCR-ABL1+ (CML). CML is a myeloproliferative neoplasm arising at the level of a pluripotent stem cell and consistently associated with the BCR-ABL1 fusion gene. CML most commonly manifests in a chronic phase of the disease with neutrophilic leukocytosis, and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
